Developmental funds provide an essential base of support for the strategic initiatives of the Cancer Center consistent with its overall planning processes. During the current project period this support was applied in three areas: recruitment of new faculty, support of pilot projects and development of shared resources. A total of fifteen new faculty were provided with recruitment support and a significant number of these have subsequently obtained peer-reviewed funding. A total of ten pilot projects were funded over the project period with a significant publication and subsequent funding record. And finally, developmental funds supported three new shared resources which are now being presented as established facilities in this application. Without question, developmental funds have provided an excellent return on investment in all three categories of support. Given the continued growth in the Cancer Center's overall research enterprise and the successful use of developmental funds in the current project period, a new request of $525,000 per year is felt to be justified. This would be allocated as $250,000 per year for new faculty recruitment, $100,000 per year for funding of pilot projects, and $175,000 per year for development of shared resources. The new shared resource facilities that will be developed with the help of these funds include the Viral Vector Core, the Epigenomics Core, and the Cancer Therapeutics and Diagnostic Screening Facility. All three cores will address important needs of the Cancer Center and will complement the function and services of already existing cores.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA060553-15
Application #
7666668
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2008-08-01
Budget End
2009-07-31
Support Year
15
Fiscal Year
2008
Total Cost
$752,689
Indirect Cost
Name
Northwestern University at Chicago
Department
Type
DUNS #
005436803
City
Chicago
State
IL
Country
United States
Zip Code
60611
Nahum-Shani, Inbal; Smith, Shawna N; Spring, Bonnie J et al. (2018) Just-in-Time Adaptive Interventions (JITAIs) in Mobile Health: Key Components and Design Principles for Ongoing Health Behavior Support. Ann Behav Med 52:446-462
Kang, Hong-Jun; Song, Ha Yong; Ahmed, Mohamed A et al. (2018) NQO1 regulates mitotic progression and response to mitotic stress through modulating SIRT2 activity. Free Radic Biol Med 126:358-371
Long, Alan; Dominguez, Donye; Qin, Lei et al. (2018) Type 2 Innate Lymphoid Cells Impede IL-33-Mediated Tumor Suppression. J Immunol 201:3456-3464
Lewis, Phillip L; Su, Jimmy; Yan, Ming et al. (2018) Complex bile duct network formation within liver decellularized extracellular matrix hydrogels. Sci Rep 8:12220
Hong, Bong Jin; Iscen, Aysenur; Chipre, Anthony J et al. (2018) Highly Stable, Ultrasmall Polymer-Grafted Nanobins (usPGNs) with Stimuli-Responsive Capability. J Phys Chem Lett 9:1133-1139
Smith, Erica D; Garza-Gongora, Arturo G; MacQuarrie, Kyle L et al. (2018) Interstitial telomeric loops and implications of the interaction between TRF2 and lamin A/C. Differentiation 102:19-26
Hsiao, Hsi-Min; Fernandez, Ramiro; Tanaka, Satona et al. (2018) Spleen-derived classical monocytes mediate lung ischemia-reperfusion injury through IL-1?. J Clin Invest 128:2833-2847
Mehta, Amol; Awah, Chidiebere U; Sonabend, Adam M (2018) Topoisomerase II Poisons for Glioblastoma; Existing Challenges and Opportunities to Personalize Therapy. Front Neurol 9:459
Brown, Jessica H; Das, Prativa; DiVito, Michael D et al. (2018) Nanofibrous PLGA electrospun scaffolds modified with type I collagen influence hepatocyte function and support viability in vitro. Acta Biomater 73:217-227
Ntai, Ioanna; Fornelli, Luca; DeHart, Caroline J et al. (2018) Precise characterization of KRAS4b proteoforms in human colorectal cells and tumors reveals mutation/modification cross-talk. Proc Natl Acad Sci U S A 115:4140-4145

Showing the most recent 10 out of 1972 publications